We use cookies for a better user experience. Read our Privacy Policy

I Agree

Drug Eluting Balloon Market

Drug Eluting Balloon Market (Product - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon; Drug Coating Technology - Paccocath, FreePac, TransPax, EnduraCoat) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Drug-eluting balloons refer to semi-compliant angioplasty balloons that are coated with anti-proliferative medications and are dispersed in the walls of blood arteries following balloon inflation, which is typically done at minimal pressures. These balloons greatly reduce cellularity and remove the need for repeated vascularization. The increasing vascular disease rates, increased product advancements, and rising elderly population are all contributing to increasing demand for the drug-eluting balloon in the healthcare industry. However, the global drug eluting balloon market is predicted to develop slowly owing to the high cost of processes and goods, as well as tight regulatory rules.

Increasing Initiatives from Government and Private Players to Drives Sales Opportunities in the Market

Over the last decade, the healthcare infrastructure has seen significant changes as technology has advanced and healthcare research has exploded. Some of the causes driving demand for drug eluting balloon catheters are increasing incidences of obesity, an aging population, and a rise in occurrence of coronary artery disease. Stents that are utilized with a balloon catheter are referred to as balloon expandable stents, as opposed to self-expandable stents, which are often composed of nitinol alloy.

The global drug eluting balloon market is also benefiting from the increasing adoption of angioplasty balloons for patients who do not gain from percutaneous coronary intervention (PCI). Governments and other organizations are increasingly supporting research and providing financing to further develop drug eluting balloon catheters.

drug eluting balloons market

Drug eluting devices are used to lessen the incidence of restenosis and are most commonly connected with cardiac problems. Over the next 10 years, the market for peripheral drug-coated balloon catheters is expected to expand at a stable growth rate. As the benefits of drug-eluting balloon catheters are discovered and treatments become more inexpensive, the use of these catheters for peripheral artery operations is expected to rise.

Demand for coronary artery disease drug eluting balloon catheters is expected to account for over 80% of market share when it comes to value in the indication segment. Despite a small market share, the demand for drug-eluting balloon catheters for peripheral vascular disease is expected to grow at a stable CAGR in the years to come. With additional angioplasty balloons being studied and manufactured, sales of peripheral drug-coated balloon catheters are expected to rise as well.

Cardiovascular illnesses are a serious public-health concern. Peripheral artery disease (PAD) is a prevalent kind of peripheral vascular disease that affects persons over the age of 65 years. PAD causes the walls of arteries to thin, slowing blood flow. Although it most usually affects the peripheral areas, it can also damage the arteries that bring blood from the head to the heart, kidneys, and stomach. Given the rising prevalence of cardiovascular illnesses, it's critical to comprehend the elements that influence the extent of the diseases and the effective treatment choices available. A number of governmental and private players are making serious efforts through various initiatives in reducing the prevalence of cardiovascular disease. Governments  as well as physicians and in industrialized nations have begun to inform the common people about PAD.

Every September, medical device firms, doctors, payers, and health care providers in the U.S. commemorate 'PAD Awareness Month.' During the awareness initiative, they strive to inform people about the ill effects of PAD and how to manage it. Several government agencies are funding research groups to help them produce drug-eluting balloons that are more successful in treating cardiovascular disorders. In the forthcoming years, this is anticipated to boost the global drug eluting balloon market.

North America and Asia Pacific to Lead the Market due to High Prevalence of Cardiovascular Illnesses

North America region is expected to account for a prominent share in the global drug eluting balloon market. High rate of treatment as well as diagnosis of cardiovascular illnesses and increasing spending on healthcare is anticipated to augur well for the drug eluting balloon market in North America. Besides, greater penetration of innovative products along with favorable reimbursement policies is expected to drive sales growth in the regional market.

However, the expiration of TPT reimbursement on medication eluting balloons in December 2017 and ' tight regulatory system in the U.S. are expected to limit the drug eluting balloon market's growth in North America over the next two to three years. Due to the growing senior population, need for higher quality of care, and rise in the prevalence of cardiovascular illnesses in the area, the drug eluting balloon market in Asia Pacific is expected to provide substantial potential throughout the projected period.

The global drug eluting balloon market has been segmented as follows:

Product

  • Coronary Drug Eluting Balloon
  • Peripheral Drug Eluting Balloon
  • Others

Technology

 

  • Paccocath
  • FreePac
  • TransPax
  • EnduraCoat
  • Others

End-user

  • Hospitals and Ambulatory Surgery Centers
  • CATH Labs
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Frequently Asked Questions

What is the total market worth of drug eluting balloon market?

The global drug eluting balloon market was worth US$ 420 Mn and is projected to reach a value of US$ 1800 Mn by the end of 2026

What is the anticipated CAGR of the drug eluting balloon market in the forecast period?

Drug eluting balloon market is anticipated to grow at a CAGR of 18% during the forecast period

Which region is expected to project the highest market share in the global drug eluting balloon market?

North America accounted for a major share of the global drug eluting balloon market

What are the key driving factors for the growth of the drug eluting balloon market?

Drug eluting balloon market is driven by increasing incidences of obesity, an aging population, and a rise in occurrence of coronary artery disease

Who are the key players in the global drug eluting balloon market?

Key players in the global drug eluting balloon market include Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc, and Biotronik

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Drug Eluting Balloon Market

    4. Market Overview
         4.1. Introduction
                4.1.1. Product Type Definition
                4.1.2. Industry Evolution / Developments
         4.2. Overview
         4.3. Market Dynamics
                4.3.1. Drivers
                4.3.2. Restraints
                4.3.3. Opportunities
         4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2016–2026
                4.4.1. Market Revenue Projections (US$ Mn)

    5. Market Outlook
         5.1. Reimbursement Scenario
         5.2. Cardiovascular Disease Prevalence
         5.3. Key Mergers & Acquisitions 
         5.4. Key Market Trends

    6. Global Drug Eluting Balloon Market Analysis and Forecast, by Product Type 
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Market Value Forecast, by Product Type, 2016–2026
                6.3.1. Coronary Drug Eluting Balloon
                6.3.2. Peripheral Drug Eluting Balloon 
                6.3.3 Others
         6.4. Market Attractiveness, by Product Type

    7. Global Drug-Eluting Balloon Market Analysis and Forecast, by Drug Coating Technology 
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Market Value Forecast, by Drug Coating Technology, 2016–2026
                7.3.1. Paccocath
                7.3.2. FreePac
                7.3.3. TransPax
                7.3.4. EnduraCoat
                7.3.5. Others
         7.4. Market Attractiveness, by Drug Coating Technology

    8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user 
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Market Value Forecast, by End-user, 2016–2026
                8.3.1. Hospitals & Ambulatory Surgical Centers 
                8.3.2. Cath Labs 
                8.3.3. Others
         8.4. Market Attractiveness, by End-user

    9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region
         9.1. Key Findings
         9.2. Market Value Forecast, by Region
                9.2.1. North America 
                9.2.2. Europe 
                9.2.3. Asia Pacific 
                9.2.4. Latin America 
                9.2.5. Middle East & Africa 
         9.3. Market Attractiveness, by Country/Region

    10. North America Drug Eluting Balloon Market Analysis and Forecast
         10.1. Introduction
                10.1.1. Key Findings
         10.2. Market Value Forecast, by Product Type, 2016–2026
                10.2.1. Coronary Drug Eluting Balloon
                10.2.2. Peripheral Drug Eluting Balloon
                10.2.3. Others
         10.3. Market Value Forecast, by Drug Coating Technology, 2016–2026
                10.3.1. Paccocath
                10.3.2. FreePac 
                10.3.3. TransPax
                10.3.4. EnduraCoat 
                10.3.5. Others
         10.4. Market Value Forecast, by End-user, 2016–2026
                10.4.1. Hospitals & Ambulatory Surgical Centers
                10.4.2. Cath Labs 
                10.4.3. Others
         10.5. Market Value Forecast, by Country, 2016–2026
                10.5.1. U.S.
                10.5.2. Canada
         10.6. Market Attractiveness Analysis 
                10.6.1. By Product Type 
                10.6.2. By Drug Coating Technology
                10.6.3. By End-user 
                10.6.4. By Country

    11. Europe Drug Eluting Balloon Market Analysis and Forecast
         11.1.Introduction
                11.1.1. Key Findings
         11.2.Market Value Forecast, by Product Type, 2016–2026
                11.2.1. Coronary Drug Eluting Balloon
                11.2.2. Peripheral Drug Eluting Balloon
                11.2.3 Others
         11.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
                11.3.1. Paccocath
                11.3.2. FreePac 
                11.3.3. TransPax
                11.3.4. EnduraCoat 
                11.3.5. Others
         11.4.Market Value Forecast, by End-user, 2016–2026
                11.4.1. Hospitals & Ambulatory Surgical Centers
                11.4.2. Cath Labs 
                11.4.3. Others
         11.5.Market Value Forecast, by Country/Sub-region, 2016–2026
                11.5.1. Germany
                11.5.2. U.K.
                11.5.3. France
                11.5.4. Italy
                11.5.5. Spain
                11.5.6. Rest of Europe
         11.6.Market Attractiveness Analysis 
                11.6.1. By Product Type 
                11.6.2. By Drug Coating Technology
                11.6.3. By End-user 
                11.6.4. By Country/Sub-region

    12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast
         12.1.Introduction
                12.1.1. Key Findings
         12.2.Market Value Forecast, by Product Type, 2016–2026
                12.2.1. Coronary Drug Eluting Balloon
                12.2.2. Peripheral Drug Eluting Balloon
                12.2.3. Others
         12.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
                12.3.1. Paccocath
                12.3.2. FreePac 
                12.3.3. TransPax
                12.3.4. EnduraCoat 
                12.3.5. Others
         12.4.Market Value Forecast, by End-user, 2016–2026
                12.4.1. Hospitals & Ambulatory Surgical Centers
                12.4.2. Cath Labs 
                12.4.3. Others
         12.5.Market Value Forecast, by Country/Sub-region, 2016–2026
                12.5.1. China
                12.5.2. Japan
                12.5.3. India
                12.5.4. Australia & New Zealand
                12.5.5. Rest of Asia Pacific
         12.6.Market Attractiveness Analysis 
                12.6.1. By Product Type 
                12.6.2. By Drug Coating Technology
                12.6.3. By End-user 
                12.6.4. By Country

    13. Latin America Drug Eluting Balloon Market Analysis and Forecast
         13.1.Introduction
                13.1.1. Key Findings
         13.2.Market Value Forecast, by Product Type, 2016–2026
                13.2.1. Coronary Drug Eluting Balloon
                13.2.2. Peripheral Drug Eluting Balloon
                13.2.3 Others
         13.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
                13.3.1. Paccocath
                13.3.2. FreePac 
                13.3.3. TransPax
                13.3.4. EnduraCoat 
                13.3.5. Others
         13.4.Market Value Forecast, by End-user, 2016–2026
                13.4.1. Hospitals & Ambulatory Surgical Centers
                13.4.2. Cath Labs 
                13.4.3. Others
         13.5.Market Value Forecast, by Country/Sub-region, 2016–2026
                13.5.1. Brazil
                13.5.2. Mexico
                13.5.3. Rest of Latin America
         13.6.Market Attractiveness Analysis 
                13.6.1. By Product Type 
                13.6.2. By Drug Coating Technology
                13.6.3. By End-user 
                13.6.4. By Country/Sub-region

    14. Middle East & Africa Drug-Eluting Balloon Market Analysis and Forecast
         14.1.Introduction
                14.1.1. Key Findings
         14.2.Market Value Forecast, by Product Type, 2016–2026
                14.2.1. Coronary Drug Eluting Balloon
                14.2.2. Peripheral Drug Eluting Balloon
                14.2.3 Others
         14.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
                14.3.1. Paccocath
                14.3.2. FreePac 
                14.3.3. TransPax
                14.3.4. EnduraCoat 
                14.3.5. Others
         14.4.Market Value Forecast, by End-user, 2016–2026
                14.4.1. Hospitals & Ambulatory Surgical Centers
                14.4.2. Cath Labs 
                14.4.3. Others
         14.5.Market Value Forecast, by Country/Sub-region, 2016–2026
                14.5.1. GCC Countries
                14.5.2. South Africa
                14.5.3. Israel
                14.5.4. Rest of Middle East & Africa 
         14.6.Market Attractiveness Analysis 
                14.6.1. By Product Type 
                14.6.2. By Drug Coating Technology
                14.6.3. By End-user 
                14.6.4. By Country/Sub-region

    15. Competition Landscape
         15.1.Market Player – Competition Matrix (by Tier and Size of companies)
         15.2.Market Share Analysis, by Company (2017)
         15.3. Competitive Business Strategies
         15.4. Company Profiles
                15.4.1. Bayer AG
                          15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.1.2. Product Portfolio
                          15.4.1.3. SWOT Analysis
                          15.4.1.4. Strategic Overview
                          15.4.1.5. Financial Overview
                15.4.2. Medtronic
                          15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.2.2. Product Portfolio
                          15.4.2.3. SWOT Analysis
                          15.4.2.4. Strategic Overview
                          15.4.2.5. Financial Overview
                15.4.3. B. Braun Melsungen AG
                          15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.3.2. Product Portfolio
                          15.4.3.3. SWOT Analysis
                          15.4.3.4. Strategic Overview
                          15.4.3.5. Financial Overview
                15.4.4. Cook Medical, Inc.
                          15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.4.2. Product Portfolio
                          15.4.4.3. SWOT Analysis
                          15.4.4.4. Strategic Overview
                          15.4.4.5. Financial Overview
                15.4.5. Boston Scientific Corporation
                          15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.5.2. Product Portfolio
                          15.4.5.3. SWOT Analysis
                          15.4.5.4. Strategic Overview
                          15.4.5.5. Financial Overview
                15.4.6. Becton, Dickinson and Company
                          15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.6.2. Product Portfolio
                          15.4.6.3. SWOT Analysis
                          15.4.6.4. Strategic Overview
                          15.4.6.5. Financial Overview
                15.4.7. EuroCor
                          15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.7.2. Product Portfolio
                          15.4.7.3. SWOT Analysis
                          15.4.7.4. Strategic Overview
                          15.4.7.5. Financial Overview
                15.4.8. Terumo Corporation
                          15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.8.2. Product Portfolio
                          15.4.8.3. SWOT Analysis
                          15.4.8.4. Strategic Overview
                          15.4.8.5. Financial Overview
                15.4.9. Koninklijke Philips N.V
                          15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.9.2. Product Portfolio
                          15.4.9.3. SWOT Analysis
                          15.4.9.4. Strategic Overview
                          15.4.9.5. Financial Overview
                15.4.10. Other Prominent Players
                          15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                          15.4.10.2. Product Portfolio
                          15.4.10.3. SWOT Analysis
                          15.4.10.4. Strategic Overview
                          15.4.10.5. Financial Overview

    List of Tables

    Table 1: Key Mergers and Acquisitions on Drug Eluting Balloon
    Table 2: Snapshot of Ongoing Research on Drug Eluting Balloon
    Table 3: Recent Patents on Drug Eluting Balloon
    Table 4: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
    Table 5: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
    Table 6: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
    Table 7: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Region, 2016-2026
    Table 8: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country, 2016–2026
    Table 9: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
    Table 10: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
    Table 11: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 12: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 13: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
    Table 14: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
    Table 15: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 16: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
    Table 17: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
    Table 18: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
    Table 19: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
    Table 20: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
    Table 21: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
    Table 22: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
    Table 23: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
    Table 24: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region,
    Table 25: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
    Table 26: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
    Table 27: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026

    List of Figures

     

    Figure 1: Global Drug Eluting Balloon Market Size (US$ Mn) and Distribution, by Geography, 2017 and 2026

    Figure 2: Global Drug Eluting Balloon Market (US$ Mn), by Key Segment, 2017

    Figure 3: Global Drug Eluting Balloon Market (US$ Mn), by Key Segment and Market Share (%), 2017

    Figure 4: Global Drug Eluting Balloon Market (US$ Mn), by Market Share (%), 2017

    Figure 5: Global Drug Eluting Balloon Market (US$ Mn), by Region (%), 2017

    Figure 6: Global Drug Eluting Balloon Market Opportunity Map, by Product Type

    Figure 7: Global Drug Eluting Balloon Market Opportunity Map, by Drug Coating Technology

    Figure 8: Global Drug Eluting Balloon Market Opportunity Map, by End-user

    Figure 9: Key Industry Evolution/Developments

    Figure 10: Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026

    Figure 11: Global Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

    Figure 12: Global Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026

    Figure 13: Coronary Drug Eluting Balloon Segment

    Figure 14: Peripheral Drug Eluting Balloon Segment

    Figure 15: Others Segment

    Figure 16: Global Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

    Figure 17: Global Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026

    Figure 18: Paccocath Segment

    Figure 19: TransPax Segment

    Figure 20: FreePac Segment

    Figure 21: EnduraCoat Segment

    Figure 22: Others Segment

    Figure 23: Global Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

    Figure 24: Global Drug Eluting Balloon Market Attractiveness, End-user 2018-2026

    Figure 25: Hospitals and ASCs Segment

    Figure 26: CATH Labs segment

    Figure 27: Others Segment

    Figure 28: Global Drug Eluting Balloon Market Value Share, by Region, 2017 and 2026

    Figure 29: Global Drug Eluting Balloon Market Attractiveness, Region

    Figure 30: North America Drug Eluting Balloons Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

    Figure 31: North America Drug Eluting Balloon Market Value Share, by Country, 2017 and 2026

    Figure 32: North America Drug Eluting Balloon Market Attractiveness, by Country, 2018–2026

    Figure 33: North America Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

    Figure 34: North America Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026

    Figure 35: North America Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

    Figure 36: North America Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026

    Figure 37: North America Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

    Figure 38: North America Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026

    Figure 39: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

    Figure 40: Europe Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026

    Figure 41: Europe Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018–2026

    Figure 42: Europe Drug Eluting Balloons Market Value Share, by Product Type, 2017 and 2026

    Figure 43: Europe Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026

    Figure 44: Europe Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

    Figure 45: Europe Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026

    Figure 46: Europe Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

    Figure 47: Europe Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026

    Figure 48: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026

    Figure 49: Asia Pacific Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026

    Figure 50: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026

    Figure 51: Asia Pacific Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

    Figure 52: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026

    Figure 53: Asia Pacific Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

    Figure 54: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026

    Figure 55: Asia Pacific Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

    Figure 56: Asia Pacific Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026

    Figure 57: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026

    Figure 58: Latin America Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026

    Figure 59: Latin America Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026

    Figure 60: Latin America Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

    Figure 61: Latin America Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026

    Figure 62: Latin America Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

    Figure 63: Latin America Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026

    Figure 64: Latin America Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

    Figure 65: Latin America Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026

    Figure 66: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

    Figure 67: Middle East & Africa Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026

    Figure 68: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018–2026

    Figure 69: Middle East & Africa Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026

    Figure 70: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026

    Figure 71: Middle East & Africa Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026

    Figure 72: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026

    Figure 73: Middle East & Africa Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026

    Figure 74: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026

Google translate

Copyright © Transparency Market Research, Inc. All Rights reserved